Covered recipient · General Payments record
KATHRYN LEILANI ACKERMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$1,568.30
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $366.26 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sage Therapeutics, Inc. | $94.95 | 4 |
| ABBVIE INC. | $61.09 | 3 |
| PFIZER INC. | $40.20 | 2 |
| Organon LLC | $31.04 | 1 |
| Sumitomo Pharma America, Inc. | $26.17 | 1 |
| Astellas Pharma US Inc | $23.15 | 1 |
| Aspira Women's Health Inc | $22.93 | 1 |
| Evofem Biosciences, Inc. | $22.42 | 1 |
| Exact Sciences Corporation | $22.17 | 1 |
| Agile Therapeutics, Inc. | $22.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.12 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106408431 | CMS |
| ABBVIE INC. | $21.46 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106408433 | CMS |
| ABBVIE INC. | $15.51 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106408435 | CMS |
| Agile Therapeutics, Inc. | $22.14 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154840708 | CMS |
| Aspira Women's Health Inc | $22.93 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126777285 | CMS |
| Astellas Pharma US Inc | $23.15 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139533610 | CMS |
| Evofem Biosciences, Inc. | $22.42 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091275580 | CMS |
| Exact Sciences Corporation | $22.17 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114506742 | CMS |
| Organon Llc | $31.04 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136209785 | CMS |
| PFIZER INC. | $17.42 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131307345 | CMS |
| PFIZER INC. | $22.78 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131625268 | CMS |
| Sage Therapeutics, Inc. | $27.46 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120392397 | CMS |
| Sage Therapeutics, Inc. | $33.10 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120398575 | CMS |
| Sage Therapeutics, Inc. | $17.76 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120403562 | CMS |
| Sage Therapeutics, Inc. | $16.63 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120408949 | CMS |
| Sumitomo Pharma America, Inc. | $26.17 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148940125 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.